HELENA ROUCO TABOADA

Helena Roco Taboada is an Interim Lecturer in the Department of Pharmacology, Pharmacy and Pharmaceutical Technology at the University of Santiago de Compostela. She holds a PhD from the same institution for her thesis on 'Quality-by-design approach for the development of lipid-based nanosystems for anti-mycobacterial therapy' (2021), supervised by Dr. Mariana Landín Pérez and Dr. Carmen Remuñán López. She is affiliated with the Faculty of Sciences and is part of the Strategic Grouping in Materials (AEMAT) and the ID-FARMA research group focusing on dosage forms and drug release systems.

Her research interests center on pharmaceutical technology, drug delivery systems, and nanomedicine, with a focus on applications in anti-mycobacterial therapy, osteoporosis treatment, and bone regeneration. Her work integrates lipid-based nanosystems, targeted drug delivery, and AI-driven formulation strategies. Recent projects include developing lipid nanoparticles for clofazimine delivery and thermosensitive hydrogels for osteoarthritis management.

Her publications span topics like nanoparticle functionalization, cryoprotectant optimization in lyophilization, and AI tools for nanostructured lipid carrier design. She is active in interdisciplinary collaborations within materials science and biomedical engineering.